Skip to main content

Safety Observer

Latest report   October 2026

Safety Observer 237

The FDA published new information on ICH E2B(R3), which became mandatory for all postmarketing ICSRs submitted via ESG NextGen.

Released 07-Oct-2026

Subscribe

Past Reports

Sign up for alerts

Receive alerts and news on pharmacovigilance regulatory requirements every month.

Register today!

Safety Observer

EUR (€) ^
My account

Social

3-Month Plan

This Plan includes three consecutive reports starting with the next release. The perfect solution to test the value of our service.

Starts at 180 €

1-Year Plan

This Plan includes eleven consecutive reports starting with the next release. Includes a double issue for July/August.

Starts at 600 €

Stay in the loop

Join over 1,000 Pharmacovigilance professionals and receive our Free Content straight to your mailbox !